In addition, CD15 expression was most prominent in COVID-19 patients, particularly in severe cases, but when selecting for CD3− or CD3− CD33+ cells, convalescent patients possessed a number of CD15+ cells more similar to patients with active disease than healthy donors. This evidence concerns the gene CD33 and COVID-19.